|
KMT2A–AFDN
(HGNC:7132, HGNC:7137)
|
MONDO:0005223
(MONDO:0005223)
|
strong |
weak |
strong |
strong |
moderate |
|
|
LMNA–NTRK1
(HGNC:6636, HGNC:8031)
|
myopericytoma
(MONDO_0017349)
|
strong |
strong |
moderate |
strong |
weak |
|
|
MALT1–BCL10
(HGNC:6819, HGNC:989)
|
MALT lymphoma
(MONDO_0007650)
|
weak |
weak |
weak |
weak |
weak |
|
|
KMT2A–MLLT3
(HGNC:7132, HGNC:7136)
|
MONDO:0018874
(MONDO:0018874)
|
strong |
strong |
moderate |
strong |
moderate |
|
|
KMT2A–AFF1
(HGNC:7132, HGNC:7135)
|
MONDO:0004967
(MONDO:0004967)
|
strong |
moderate |
strong |
strong |
strong |
|
|
KMT2A–MLLT1
(HGNC:7132, HGNC:7134)
|
leukemia
(MONDO_0005059)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
LASP1–KMT2A
(HGNC:6513, HGNC:7132)
|
MONDO:0010643
(MONDO:0010643)
|
moderate |
weak |
moderate |
strong |
weak |
|
|
MET–NTRK1
(HGNC:7029, HGNC:8031)
|
MONDO:0006033
(MONDO:0006033)
|
moderate |
moderate |
moderate |
strong |
weak |
|
|
MLF1–NPM1
(HGNC:7125, HGNC:7910)
|
myelodysplastic syndrome
(MONDO_0018881)
|
strong |
strong |
moderate |
strong |
strong |
|
|
MET–PTPRZ1
(HGNC:7029, HGNC:9685)
|
MONDO:0018177
(MONDO:0018177)
|
strong |
strong |
strong |
moderate |
weak |
|
|
MEIS1–NCOA2
(HGNC:7000, HGNC:7669)
|
adenosarcoma
(MONDO_0005636)
|
strong |
weak |
moderate |
strong |
weak |
|
|
MEF2D–NTRK1
(HGNC:6997, HGNC:8031)
|
MONDO:0005212
(MONDO:0005212)
|
moderate |
moderate |
weak |
moderate |
weak |
|
|
MBD1–PDGFRB
(HGNC:6916, HGNC:8804)
|
|
weak |
weak |
weak |
weak |
weak |
|
|
MEF2D–NCOA2
(HGNC:6997, HGNC:7669)
|
smooth muscle tumor
(MONDO_0006975)
|
strong |
weak |
moderate |
strong |
weak |
|
|
MAP3K8–ABLIM1
(HGNC:6860, HGNC:78)
|
MONDO:0005065
(MONDO:0005065)
|
moderate |
weak |
moderate |
moderate |
weak |
|
|
BIRC3–MALT1
(HGNC:591, HGNC:6819)
|
MONDO:0007650
(MONDO:0007650)
|
strong |
moderate |
strong |
strong |
weak |
|
|
KIF5B–MET
(HGNC:6324, HGNC:7029)
|
lung adenocarcinoma
(MONDO_0005061)
|
strong |
strong |
moderate |
strong |
weak |
|
|
KIF5B–RET
(HGNC:6324, HGNC:9967)
|
MONDO:0005061
(MONDO:0005061)
|
strong |
strong |
moderate |
strong |
weak |
|
|
KDR–PDGFRA
(HGNC:6307, HGNC:8803)
|
MONDO:0016695
(MONDO:0016695)
|
moderate |
strong |
moderate |
moderate |
weak |
|
|
JAK2–MBD1
(HGNC:6192, HGNC:6916)
|
precursor B-cell acute lymphoblastic leukemia
(MONDO_0020511)
|
weak |
weak |
weak |
weak |
weak |
|